US Patent Issued to KOREA ATOMIC ENERGY RESEARCH INSTITUTE on June 9 for "Composition comprising EMP3 inhibitor for inhibiting growth of cancer stemcell and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,923, issued on June 9, was assigned to KOREA ATOMIC ENERGY RESEARCH INSTITUTE (Daejeon, South Korea).

"Composition comprising EMP3 inhibitor for inhibiting growth of cancer stemcell and use thereof" was invented by In Gyu Kim (Daejeon, South Korea), Rae Kwon Kim (Sejong, South Korea) and Yeon Jee Kahm (Hwaseong-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a composition for inhibiting the growth of cancer stem cells and a use thereof. When treated with the EMP3 inhibitor, cancer stem cells expressing ALDH1 decrease in self-renewal potential, invasiveness, and migration ability and thus are restrained ...